secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amylyx Pharmaceuticals, Inc. (AMLX)
CIK:        0001658551
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0001193125-25-135860
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Amylyx shareholders elect three Class I directors; ratify Deloitte; approve say-on-pay proposal
--------------------------------------------------------------------------------

- Karen Firestone, Justin Klee, and Bernhardt Zeiher elected as Class I directors for term ending 2028. Firestone and Zeiher each had ~21.3M votes withheld; Klee had 1.5M.
- Ratification of Deloitte & Touche as auditor for FY 2025 passed with 72.5M for vs 34.7K against.
- Non-binding advisory vote on executive compensation passed with 33.1M for, 24.1M against, and 2.0M abstentions.
- Total shares voted: ~72.5M on auditor proposal; broker non-votes of 15.4M on director elections and say-on-pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658551/000119312525135860/0001193125-25-135860-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658551/000119312525135860/d920336d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-135860

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer